fda bpc 157 compounding category 2 list The just announced that they're taking steps to lift restrictions on 12 peptides — including BPC-157 and TB-500 — making them accessible through pharmacies again. This is a HUGE step BPC-157 FDA Approval Status 2026:
BPC 157 FDA Approval Status 2026: Clinical Trials FDA Removes Peptides from Category 2 List, Paving Way for Regulation Jonathan Cole posted on the topic LinkedIn FDA mulls compounding for peptides previously flagged over safety risks BioSpace Peptide Update: What This Could Mean for Medicine The FDA may move 14 peptides from Category 2 to Category 1, which would make them FDA recognized and legally prescribable. Why this matters
Pay in 4 interest-free payments of $5.64 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

